Serum Interleukin-33 in Rheumatoid Arthritis and its Relation to Disease Activity

The Use of Interleukin-22 as a Novel Marker of Disease Activity in Female Patients with Rheumatoid Arthritis

ROLE OF INTERLEUKIN-23 AS A MARKER OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS

Interleukin-10, Interleukin- 16 and Interferon-γ in serum of patients with rheumatoid arthritis and correlation with disease activity

Serum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Pathogenic Role of Interlukin-23(IL-23) in Rheumatoid Arthritis Patients; its Relation to Disease Activity

EVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS

Serum Levels Of Interleukin–12 And Tumour Necrosis Factor– In Patients With Active And Inactive Rheumatoid Arthritis

Serum level of Interleukin-33 and relation to disease activity in Juvenile Idiopathic Arthritis